Roche Invests $50 Billion in U.S., Creating Over 12,000 Jobs
Roche, a Swiss multinational healthcare company, will invest $50 billion in the United States over the next five years. The investment will create more than 12,000 jobs, which includes nearly 6,500 construction jobs, and 1,000 positions at new and expanded facilities. The company’s investments will add to Roche’s existing infrastructure in the U.S., where it currently has 13 manufacturing and 15 research and development sites across its pharmaceutical and diagnostics divisions. These expansions and new facilities are poised to significantly bolster Roche’s presence and operations within the United States.
Newsflash | Powered by GeneOnline AI
Date: May 8, 2025
LATEST
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20